ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 140 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,000 | -7.1% | 7,478 | +67.2% | 0.00% | – |
| Q2 2023 | $42,000 | +13.5% | 4,472 | +33.3% | 0.00% | – |
| Q1 2023 | $37,000 | -61.5% | 3,354 | -48.2% | 0.00% | – |
| Q4 2022 | $96,000 | +357.1% | 6,478 | +473.8% | 0.00% | – |
| Q3 2022 | $21,000 | +50.0% | 1,129 | +73.2% | 0.00% | – |
| Q2 2022 | $14,000 | -62.2% | 652 | -65.7% | 0.00% | – |
| Q1 2022 | $37,000 | -65.1% | 1,900 | -62.8% | 0.00% | – |
| Q4 2021 | $106,000 | +68.3% | 5,107 | +93.4% | 0.00% | – |
| Q3 2021 | $63,000 | +12.5% | 2,640 | +28.6% | 0.00% | – |
| Q2 2021 | $56,000 | +51.4% | 2,053 | +59.8% | 0.00% | – |
| Q1 2021 | $37,000 | +311.1% | 1,285 | +297.8% | 0.00% | – |
| Q4 2020 | $9,000 | +800.0% | 323 | +1600.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 19 | +11.8% | 0.00% | – |
| Q2 2020 | $1,000 | -93.8% | 17 | -96.9% | 0.00% | – |
| Q1 2020 | $16,000 | – | 557 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|